Fluororesin Products for Magnetic flow meters.

EFE-Ci EA I lb7.1 THE EUROPEAN FEDERATION FOR COSMETIC INGREDIENTS SECTION III.

AVR Italian association of valve and tap manufacturers AVR Answer to Echa consultation on PFAS restriction: Annex Question 8.

European Semiconductor Industry Association Per- and polyfluoroalkyl substances (PFAS) ESIA comments on Annex XV restriction report Brussels, 2 June 2023 General Comments Introduction The semiconductor industry is very reliant upon many applications of materials (solids, liquid, and gases) falling under the definition of PFAS as set out in the EU REACH PFAS restriction proposal (any organic chemical with a perfluorinated methylene group (-CF2-) and/or perfluorinated methyl group (-CF3) moiety).

Feedback on the proposal on the restriction on the manufacture, placing on the market and use of PFAS.

Response to the public consultation on the global PFAS restriction project September 2023 1 Five connector manufacturers - Amphenol Socapex, Eaton Souriau ITD, ITT Cannon GmbH, Radiall SA and TE Connectivity- have decided to call on EcoMundo as an independent third party to collect, aggregate and anonymise data for their response to the public consultation on the global PFAS restriction project.

S.C.I.

SOCIO-ECONOMIC ANALYSIS Of the potential restriction of the perand polyfluoroalkyl substances (PFAS) used in the production, packaging and delivery of human medicinal products SUBSTANCES: per- and polyfluoroalkyl substances (PFAS) used for medicinal products FROM: European Federation of Pharmaceutical Industries and Associations (EFPIA) USE: For Human Medicinal Products DATE: 17 August 2023 PREPARED BY: EPPA SA/NV Place du Luxembourg 2 1050 Brussels, Belgium EU Transparency Register: 31367501249-92 SOCIO-ECONOMIC ANALYSIS | PFAS | EU REACH SOCIO-ECONOMIC ANALYSIS Of the potential restriction of the per- and polyfluoroalkyl substances (PFAS) used in the production, packaging and delivery of human medicinal products PROJECT TITLE: Socio-economic analysis of the potential restriction of the per- and polyfluoroalkyl substances (PFAS) used in the production, packaging and delivery of human medicinal products VERSION: 17 August 2023 PREPARED FOR: European Federation of Pharmaceutical Industries and Associations (EFPIA) PERFORMED BY: EPPA (www.eppa.com) CITATION: EPPA, `Socio-economic analysis of the potential restriction of the per- and polyfluoroalkyl substances (PFAS) used in the production, packaging and delivery of human medicinal products', Report for EFPIA, July 2023 DISCLAIMER: The views expressed in this report are, unless otherwise stated, those of the authors and do not necessarily represent any official view of EFPIA and/or any other organization mentioned in this report. 2 CONTENTS SOCIO-ECONOMIC ANALYSIS | PFAS | EU REACH CONTENTS......................................................................................................................... 3 ABBREVIATIONS ................................................................................................................ 5 DEFINITIONS ..................................................................................................................... 7 1.

Ionomr Innovations Inc. 2386 East Mall, Suite 111 Vancouver, BC V6T 1Z3 Canada Subject: Ionomr Innovations Inc. submission to public consultation 2023 September 23 Dear Members of the ECHA Review Committee, Thank you for taking PFAS seriously.

Statement of Endress+Hauser on Recent EU (European Union) Initiatives on Restricting PFAS (Polyfluoroalkyl Substances) Endress+Hauser recognizes the ongoing initiatives regarding restrictions on the use of PFAS due to their negative impact on the environment.

EURATEX submission to ECHA consultation on the U-PFAS restriction Proposal for best-available technology (BVT) in the context of the BREF process textile industry September 2023 Description Technical solution for the retention of residual padding liquors to avoid emissions into wastewater.

Fiflow BTX Cream at 10%(N 1904-2/2005) Panel test on 4 females Applicaton of the Fiflow BTX cream for eye area on four females, ages 53, 46, 35 and 28.

Assogomma comments on the Annex XV Dossier of the universal PFAS restriction proposal September, 6th 2023 1 1.

ESMO feedback on scientific and technical information on the manufacture, placing on the market and use of per- and polyfluoroalkyl substances (PFAS) The European Society for Medical Oncology (ESMO) is the leading professional organisation for medical oncology, with more than 30,000 members from over 160 countries.